₹ 49.87
-2.06 (-3.97%)
BSE
E
EIKO Lifesciences
₹ 49.87
BSE
EIKO Financials Summary (Consolidated)
EIKO Lifesciences revenue increased 4.65% quarter-on-quarter to ₹18 Cr in Sep 2026, while net profit increased 6.67% quarter-on-quarter to ₹2 Cr. Compared to the same quarter last year, revenue is up 50.00% and net profit is up 23.08%. EPS for the quarter stood at ₹0.93, increased from ₹0.91 in the previous quarter and up from ₹0.78 a year ago.
EIKO Lifesciences Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of EIKO Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
EIKO Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






